Across Europe CVD (cardatic disease) rates are the highest in Europe but in Spain they peak at more than 13000 per million people. Less than 8 of the population are type 1 diabetes which have a higher mortality rate.

Until 2016 the prevalence was lowest in Scotland at 5140 people a year.

In South Korea incidence rates of type 1 diabetes have dropped from 13000 in 2004 to 6800 in 2014. Sweden is closing the gap to numbers of people who develop the disease after four years of follow-up data from the Swedish national health register showed.

In a new study researchers from Karolinska Institutet presented at a congress of the European Society of Cardiology (ESC) in London on 27 April 2020 see significant increases in newly diagnosed type 1 diabetes cases in Sweden since 2012 compounding in Spain.

Lead author Kristian Andersen Bjrge Dollgren researcher at the Department of Medicine and He Skne University Hospital Stockholm Sweden and colleagues studied Swedish diabetes-related deaths from January 2008 to December 2014. Using death records with detailed information on causes of death as well as a detailed questionnaire this study looked at several risk factors for type 1 diabetes.

They estimated that between 2008 and 2014 (average annual re-emergence of type 1 diabetes was 4 years later) the incidence increased by as much as 8 per year in Spain for men and 9 per year in women.

The authors stressed that the reason the incidence in both sexes increased that much during this period was likely to be due to declining mortality rates among type 1 diabetes patients over time.

A limitation of the study was that it looked at type 1 diabetes in a population with no different causes of death than the Swedish population. It is possible that the transmission of diabetes during the time period in which there are no causes of death in this population is different than in the Swedish population.

Areas of greatest riskFor this reason the authors conclude the next areas of greatest risk should be hair-raising risk for type 1 diabetes. They point to recent improvements in diabetes prevention in the United States China and Europe. Jersey Wales and Finland had high but less so corresponding incidence rates of type 1 diabetes from 2003 to 2016 and Denmark showed an incidence rate that peaking in 2016 at 21. 1 per million Swedish.

ConclusionsRates in Europe and North America are similarly high but in Spain and the Netherlands the rises were less pronounced. The authors recommend high-risk areas should remain especially dangerous-but not yet say severe.

In the most recent European Union report on type 1 diabetes Table 17 incidence is increasing per year rising from 8 in 2004 to 14 in 2016 and rising to 21 in Spain.

These increases are presumably due in large part to increasing life-weighting. To keep the percentage of type 1 diabetes in this category low increased restrictions to disease progression should be maintained (up to 10 years or more in South and Central America and South Korea) notes Kristian Andersen Bjrge Dollgren professor at Teknologi and Karolinska Institutet.

Implications for planning policy effortsSafety of treatment and prevention depends on clinical clarity he argues. The risk of type 1 diabetes is higher than the risk of any other chronic condition and the international trend is in the right direction but on the current trend both need to be maintained at lower than mean rates he says.